Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives

Abstract excerpt

Each year, almost 4.1 million people are diagnosed with gastrointestinal (GI) cancers. Due to late detection of this disease, the mortality is high, causing approximately 3 million cancer-related deaths annually, worldwide. Although the incidence and survival differs according to organ site, earlier detection and improved prognostication have the potential to reduce overall mortality burden from these cancers....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Epigenetics and DNA Methylation
• Share to Pancreatic and Hepatic Oncology Research
• Share to RNA modifications and cancer